$6.85
▲ +0.4% Today
as of Oct 2, 16:54 ET
Last 30 days
RGC earnings at a glance
Regencell Bioscience Holdings Limited (RGC) is scheduled to report earnings on Friday, October 30, 2026 — in 25 days. The options market is pricing a move of about ±14.7% after the report, a range of roughly $5.85 to $7.85 from today's $6.85. Implied volatility is currently 94%. The share price of $6.85 sits near its 52-week low.
Overview
52-week range
$4.51
$69
4% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
94%
EM ±14.7% · $8 · Oct 16
Earnings trends
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Oct 30, 2026 | Jun/2026 | OTHER | — | — |
Implied volatility — last 90 days
RGC earnings FAQ
When is RGC's next earnings date?
Regencell Bioscience Holdings Limited is expected to report on October 30, 2026.
What is RGC's expected move for earnings?
Options currently price a move of about ±14.7%, or $1.00 per share either way from $6.85.
What is RGC's implied volatility?
RGC's at-the-money implied volatility is about 94% based on the latest options snapshot.